Kofola ČeskoSlovensko

Kofola reports revenue of 3.24 billion and EPS of 10.9 for H1 2026; revenue and profitability rose despite raw material costs. Core-business sales in July and August were 12% above last year, management kept the 2026 EBITDA guidance unchanged and sees a chance to reach the upper end of the range. The estimated cost impact of the Middle East crisis was reduced to 100–150 million CZK, and the acquisition of BOHEMIA HEALING MARIENBAD WATERS to expand into the functional mineral waters segment has been completed. » More on de.investing.com

Kofola reports mixed Q1 2026 results: strong revenue growth in Slovakia (+64% due to the acquisition of ASO VENDING) and a modest increase in the Czech Republic (+3%) were offset by a 6.5% volume decline in the beer segment. The full-year EBITDA forecast remains at 1.8–1.9 billion CZK, although the Middle East conflict is expected to burden results by around 200 million CZK. The leverage ratio rose to 3.5x, and the share fell 1.52% to 7.78. » More on de.investing.com

Kofola reports Q4 EBITDA of 415 million CZK (+58.4% year-on-year) and an adjusted EBITDA for 2025 of 1.82 billion CZK on revenue down 3.0% to 10.75 billion CZK. The result benefited from strategic cost management and margin improvements despite headwinds from the sugar tax in Slovakia, poor weather and higher distribution costs. Net debt rose to 5.49 billion CZK; the board proposes a dividend of 21 CZK per share and issues an EBITDA guidance for 2026 of 1.8–1.9 billion CZK and revenue growth of around 10% including acquisitions. » More on de.investing.com